Trade Names
Synonyms
Status
Molecule Category Free-form
ATC L01EX14
UNII L5ORF0AN1I

Structure

InChI Key HAYYBYPASCDWEQ-UHFFFAOYSA-N
Smiles CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1
InChI
InChI=1S/C31H34F2N6O2/c1-38-8-10-39(11-9-38)25-3-4-26(29(19-25)34-24-6-12-41-13-7-24)31(40)35-30-27-17-20(2-5-28(27)36-37-30)14-21-15-22(32)18-23(33)16-21/h2-5,15-19,24,34H,6-14H2,1H3,(H2,35,36,37,40)

Physicochemical Descriptors

Property Name Value
Molecular Formula C31H34F2N6O2
Molecular Weight 560.65
AlogP 5.03
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 7.0
Polar Surface Area 85.52
Molecular species NEUTRAL
Aromatic Rings 4.0
Heavy Atoms 41.0

Pharmacology

Mechanism of Action Action Reference
ALK tyrosine kinase receptor inhibitor INHIBITOR FDA
EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Homo sapiens
- 0.22-897 - 6.2 21-54.1

Target Conservation

Protein: Proto-oncogene tyrosine-protein kinase ROS

Description: Proto-oncogene tyrosine-protein kinase ROS

Organism : Homo sapiens

P08922 ENSG00000047936
Protein: ALK tyrosine kinase receptor

Description: ALK tyrosine kinase receptor

Organism : Homo sapiens

Q9UM73 ENSG00000171094

Cross References

Resources Reference
ChEMBL CHEMBL1983268
DrugBank DB11986
DrugCentral 5345
FDA SRS L5ORF0AN1I
Guide to Pharmacology 8290
PDB YMX
PubChem 25141092
SureChEMBL SCHEMBL3512601
ZINC ZINC000043204146